@article{9b2f43e754ac4deca757381536bd92d7,
title = "Best Endovascular versus Best Surgical Therapy in Patients with CLI (BEST-CLI) Trial: A Misleading Trial Name",
author = "Takahashi, {Edwin A.} and Lookstein, {Robert A.} and Sanjay Misra",
note = "Funding Information: E.A.T. is a member of the Data and Safety Monitoring Board for Alucent Biomedical. S.M. is the principal investigator of research grant HL098967 and the Regenerative Minnesota Medicine Grant, is a consultant for Medtronic, is the founder of Pavaj Vascular, reports equity from Inova Vascular; is a member of the Data and Safety Monitoring Boards for Humacyte and Penumbra, and is the outgoing chair for the American Heart Association's Council on Cardiovascular Radiology and Intervention. R.A.L. reports institutional grants from Penumbra, Boston Scientific, Black Swan, and Terumo; reports consulting fees from Penumbra, Neptune, and Truvic; reports honoraria from Boston Scientific; reports payment for expert testimony from Broening Oberg Woods & Wilson, Notified, and Crowell & Moring; is a member of the Data and Safety Monitoring Board or Advisory Board for Boston Scientific and Medtronic; was the past president of Pet Consortium; and reports stock options in Inova Vascular, Truvic, and Sonovascular. ",
year = "2023",
month = apr,
doi = "10.1016/j.jvir.2023.01.005",
language = "English (US)",
volume = "34",
pages = "718--719",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "4",
}